Bausch Health to redeem C$100 million 6 1/8% notes due 2025

By Rebecca Melvin

Concord, N.H., May 27 – Bausch Health Cos. Inc. announced it will reduce debt by about C$100 million through redemption of outstanding senior notes, using cash flow from operations.

Bausch Health will redeem C$100 million principal amount of its 6 1/8% senior notes due 2025 (Cusips; 91831AAC5, C96729AC9) on June 30, according to a company news release.

Upon completion of the redemption, the company will have redeemed a total of C$500 million aggregate principal amount of debt in 2021 using cash generated from operations.

Payment of the redemption price and surrender of the notes for redemption will be made through the Depository Trust Co.

Based in Laval, Quebec, Bausch develops, manufactures and markets pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.